Grants - Designated Grants - California - 2020

Angelique Richardson, MD, PhD

Funded by Hooters of America, LLC

One in every eight women will be diagnosed with breast cancer in a lifetime. But it doesn’t impact everyone equally. While Caucasian women are more likely to be diagnosed with breast cancer, African- American (AA) women are more likely to die from the disease. In addition, AA women are more likely to be diagnosed at a younger age and have a more aggressive form of breast cancer. There have been many improvements in the treatment of breast cancer leading to a lower chance of dying from the disease. But AA women have not been shown to benefit as much as Caucasian women from these advancements. There are many factors believed to be the reason for this racial difference in survival. But there is a need for more research into this area. One way to better study these factors is within the context of a clinical trial. AA women are historically less likely to be in a cancer clinical trial study. This proposed study is aimed at increasing the enrollment of AA female breast cancer patients in clinical trials at UCSD by creating a clinical trial education program to both educate and engage the community. This is predicted to lead to a decrease in the current breast cancer survival disparity.